Clinical Trial

Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized, double-blind, placebo-controlled clinical study is designed to evaluate the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) in improving women's sexual wellness. Sexual wellness is assessed as a multidimensional construct encompassing sexual function, sexual distress, sexual satisfaction, perceived stress, quality of life, and physiological stress markers. Participants will receive either Shatavari root extract or placebo for 12 weeks, with assessments conducted at baseline and follow-up visits.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-28
notable Primary completion pushed: 2026-06-22 -> 2026-07-30 2026-04-28
minor Completion pushed: 2026-07-10 -> 2026-08-15 2026-04-28
Trial Details
NCT Number NCT07441083
Lead Sponsor SF Research Institute, Inc.
Collaborators: Ixoreal Biomed Private Limited
Conditions Sexual Wellness, Women Health
Enrollment 60 participants
Start Date 2026-04-29
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-27